Podcast

Trending News – August 18th, 2022

Play this Episode

In this minisode, Mindy is joined by Vynamic’s Brian Schachter to discuss a few recent newsworthy items including: the Inflation Reduction Act signed by President Biden (00:50), the FDA granting Zynteglo a priority review (09:01), and the primary care market that is being reinvigorated by new entrants who are placing big bets on the healthcare system (14:40).

 

Podcast Tags: healthcare, healthcare news, life sciences, Inflation Reduction Act, Medicare, Zynteglo, primary care, value-based care, BlueBird Bio

Source Links:

· https://www.hhs.gov/about/news/2022/08/07/statement-by-hhs-secretary-xavier-becerra-on-senate-passage-of-the-inflation-reduction-act.html#:~:text=The%20Inflation%20Reduction%20Act%20locks,prescription%20drugs%20that%20they%20need.

· https://www.cnn.com/2022/08/07/politics/senate-democrats-climate-health-care-bill-vote/index.html

· https://www.cbsnews.com/news/insulin-price-cap-senate-republicans-block-inflation-reduction-act/

· https://www.google.com/search?q=FDA+to+approve+zynteglo&rlz=1C1GCEB_enUS943US943&oq=FDA+to+approve+zynteglo&aqs=chrome..69i57j33i160l2.3511j0j7&sourceid=chrome&ie=UTF-8

· https://endpts.com/bluebird-bio-may-finally-get-a-gene-therapy-approved-in-the-us/

· https://www.fiercepharma.com/pharma/cell-and-gene-therapy-makers-push-past-regulatory-payer-hurdles-to-set-up-high-hopes-for

· https://www.fiercehealthcare.com/providers/retailers-payers-and-startups-could-capture-30-primary-care-market-2030-report

 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

 

Mindy McGrath, Healthcare Industry Advisor

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

 

Brian Schachter, Manager

[email protected]

Want to learn more? Get in Touch!

Contact our team to learn more about how we can help your needs.

Let's Talk

Send us a message and we'll get back to you shortly.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.